Fermentation supernatants of lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1738-1742

  Wan, Ying ^a   Xin, Yi ^a   Zhang, Cuili ^a   Wu, Dachang ^a   Ding, Dapeng ^a   Tang, Li ^a   Owusu, Lawrence ^a   Bai, Jing ^a   Li, Weiling ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Colon cancer; Lactobacillus delbrueckii; Matrix metalloproteinase 9

Indexed keywords

BETA ACTIN; CASPASE 3; CASPASE 8; GELATIN; GELATINASE B; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ASSAY; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY ASSAY; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FERMENTATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LACTOBACILLUS DELBRUECKII; POLYACRYLAMIDE GEL ELECTROPHORESIS; STAINING; SUPERNATANT; TUMOR INVASION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84896284614     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1959     Document Type: Article

References (16)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Watson AJ and Collins PD: Colon cancer: a civilization disorder. Dig Dis 29: 222-228, 2011.
3. Tjalsma H, Boleij A, Marchesi JR, et al: A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10: 575-582, 2012.
4. Antonic V, Stojadinovic A, Kester KE, et al: Significance of infectious agents in colorectal cancer development. J Cancer 4: 227-240, 2013.
5. Rafter J: Probiotics and colon cancer. Best Pract Res Clin Gastroenterol 17: 849-859, 2003.
6. Rafter J: Lactic acid bacteria and cancer: mechanistic perspective. Br J Nutr 88 (Suppl 1): S89-S94, 2002.
7. Narushima S, Sakata T, Hioki K, et al: Inhibitory effect of yogurt on aberrant crypt foci formation in the rat colon and colorectal tumorigenesis in RasH2 mice. Exp Anim 59: 487-494, 2010.
8. Fulda S and Debatin KM: Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets 4: 569-576, 2004.
9. Yang J, Liu X, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
10. Stetler-Stevenson WG and Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 11: 143-152, 2001.
11. Decock J, Thirkettle S, et al: Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med 15: 1254-1265, 2011.
12. Kanavos P: The rising burden of cancer in the developing world. Ann Oncol 17 (Suppl 8): viii15-viii23, 2006.
13. Wollowski I, Rechkemmer G and Pool-Zobel BL: Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73 (Suppl 2): S451-S455, 2001.
14. Asha and Gayathri D: Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice. Exp Ther Med 3: 1049-1054, 2012.
15. Zucker S and Vacirca J: Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23: 101-117, 2004.
16. Escamilla J, Lane MA and Maitin V: Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer 64: 871-878, 2012.